These PSMA-albumin binding tracers (CTT1403, RPS-027, RPS-063, DOTA-PSMA-ALB-02 and HTK01169) all successfully showed increased circulation-half-lives and tumor uptake. This evidence concerns the gene FOLH1 and neoplasm.